Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business unit. It was a scientific outpost.

I entered this field when we measured success by the depth of a clinical conversation, not the breadth of a CRM dashboard. Today, oncology is a multi-billion-dollar strategic chess match. But as we have gained scale, there is a lingering question: have we lost the plot?

Looking back at four decades from the frontlines, the evolution of cancer care in India was not a slow climb. It was a series of radical rewiring events that changed how we think, sell, and treat.